(Q39525851)

English

Viral and inflammatory markers in cerebrospinal fluid of patients with HIV-1-associated neurocognitive impairment during antiretroviral treatment switch.

scientific article published on 27 February 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25721471%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Viral and inflammatory markers in cerebrospinal fluid of patients with HIV-1-associated neurocognitive impairment during antiretroviral treatment switch (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25721471%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

anti-retroviral agent

0 references

0 references

cerebrospinal fluid

0 references

Maria Carmen Puertas

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25721471%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Javier Martinez-Picado

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25721471%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Jose A Muñoz-Moreno

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25721471%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Carlos Alonso Villaverde

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25721471%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25721471%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

J M Tiraboschi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25721471%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

A Prats

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25721471%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

E Ferrer

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25721471%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

N Rozas

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25721471%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

M Maso

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25721471%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

D Podzamczer

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25721471%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

27 February 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25721471%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25721471%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25721471%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25721471%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

388-392

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25721471%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Neurocognitive impairment in HIV-infected naïve patients with advanced disease: the role of virus and intrathecal immune activation.

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12243

21 January 2018

Maraviroc versus efavirenz, both in combination with zidovudine-lamivudine, for the treatment of antiretroviral-naive subjects with CCR5-tropic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12243

21 January 2018

Maraviroc for previously treated patients with R5 HIV-1 infection

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12243

21 January 2018

Interruptions of antiretroviral therapy in human immunodeficiency virus infection: are they detrimental to neurocognitive functioning?

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12243

21 January 2018

Initial validation of a screening battery for the detection of HIV-associated cognitive impairment

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12243

21 January 2018

Clinical validation of the NeuroScreen

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12243

21 January 2018

Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12243

21 January 2018

Intensification of a raltegravir-based regimen with maraviroc in early HIV-1 infection

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12243

21 January 2018

Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12243

21 January 2018

HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12243

21 January 2018

Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12243

21 January 2018

Can high central nervous system penetrating antiretroviral regimens protect against the onset of HIV-associated neurocognitive disorders?

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12243

21 January 2018

Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12243

21 January 2018

Maraviroc-containing regimen suppresses HIV replication in the cerebrospinal fluid of patients with neurological symptoms

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12243

21 January 2018

Neuroprotective maraviroc monotherapy in simian immunodeficiency virus-infected macaques: reduced replicating and latent SIV in the brain

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12243

21 January 2018

Identifiers

10.1111/HIV.12243

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25721471%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25721471%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39525851&oldid=1625311256"